UKKA2025EN
UKKA Clinical Practice Guideline: Anticoagulants in Adults with Advanced Chronic Kidney Disease and Non-Valvular Atrial Fibrillation (October 2025)
Zusammenfassung
UK Kidney Association Clinical Practice Guideline
Clinical Practice Guideline:
Anticoagulation for atrial fibrillation in adults with
advanced kidney disease
Co-Chairs:
Kathrine Parker, Manchester University NHS Foundation trust and University of Manchester
Dr Albert Power, University of Bristol and Imperial College London
Guideline working group:
Yvonne Bernes, Sheffield Teaching Hospitals NHS Trust
Dr Kate Bramham, St Thomas’s Hospital
Dr Richard Buka, Univers
Kerninformationen
nt representative
Donna Lewis, Patient representative
Ed Jenkinson, Patient representative
Alan Craig*, Patient representative
Final version: September 2025
Review date: September 2028
UK Kidney Association Clinical Practice Guideline
2
Acknowledgements
Acknowledgements to expert...
gramme of research which forms the basis for this guideline. The views expressed in this
publication are those of the author(s) and not necessarily those of the NHS, the National Institute for
Health Research or the Department of Health and Social Care.
Prof. Sandip Mitra supervised Kathrine Par...
ound, aims and concise methods ................................................................................ 7
Section 2: Kidney function estimates for anticoagulant dosing ........................................................... 17
Section 3: The use of risk scores for stroke and bleeding a...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
UKKA2025
UKKA Clinical Practice Guideline: Anticoagulation for Venous Thromboembolism in Adults with Advanced Kidney Disease (October 2025)
National Heart Foundation of Australia / CSANZ2018
NHFA/CSANZ 2018 Guidelines for Atrial Fibrillation — Summary and Full Presentations
Cochrane2021
Cochrane Review: Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias
Cochrane2025
Cochrane Review: Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis
SIGN2021
SIGN: Prevention of Stroke in Patients with Atrial Fibrillation
CCS2022
CCS/CHRS 2022 Atrial Fibrillation Guidelines Pocket Guide
Cochrane2024
Cochrane Review: Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Cochrane2025